title: Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs.
abstract: Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.
authors.affiliation: Andrological Urology Unit, AOU di Sassari, Sassari. andro@tin.it.
authors.forename: Furio
authors.initials: F
authors.lastname: Pirozzi Farina
authors.forename: Antonella
authors.initials: A
authors.lastname: Pischedda
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000505:Alopecia / Q000188:drug therapy*; D016903:Drug Monitoring; D000068538:Dutasteride / Q000008:administration & dosage / Q000009:adverse effects*; D007172:Erectile Dysfunction / Q000209:etiology* / Q000517:prevention & control; D019317:Evidence-Based Medicine; D018120:Finasteride / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D018579:Patient Selection; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D058891:5-alpha Reductase Inhibitors; D018120:Finasteride; D000068538:Dutasteride